Skip to main content
TipRanks
Go Ultimate75% OFF

Takeda Pharmaceutical Company (TAK) Ratios

1,372 Followers

Takeda Pharmaceutical Company Ratios

TAK's free cash flow for Q2 2026 was ¥212.65B. For the 2026 fiscal year, TAK's free cash flow was decreased by ¥-44.54B and operating cash flow was ¥257.18B. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio1.271.011.110.971.21
Quick Ratio0.700.520.580.570.81
Cash Ratio0.240.150.200.210.40
Solvency Ratio0.070.120.100.130.11
Operating Cash Flow Ratio0.430.420.310.390.52
Short-Term Operating Cash Flow Coverage2.021.931.952.885.51
Net Current Asset Value¥ -4.61T¥ -4.79T¥ -5.28T¥ -5.21T¥ -4.90T
Leverage Ratios
Debt-to-Assets Ratio0.320.320.320.310.33
Debt-to-Equity Ratio0.630.650.670.690.76
Debt-to-Capital Ratio0.390.390.400.410.43
Long-Term Debt-to-Capital Ratio0.360.360.380.390.42
Financial Leverage Ratio1.992.052.082.202.32
Debt Service Coverage Ratio1.081.673.352.693.40
Interest Coverage Ratio0.042.49201.494.193.76
Debt to Market Cap0.530.630.750.650.80
Interest Debt Per Share1603.471449.081548.411449.701428.79
Net Debt to EBITDA5.923.413.833.002.95
Profitability Margins
Gross Profit Margin65.12%65.51%66.43%69.11%68.99%
EBIT Margin0.13%9.80%11.71%15.39%16.81%
EBITDA Margin16.13%26.42%26.83%31.88%33.15%
Operating Profit Margin0.14%7.48%5.02%12.18%12.91%
Pretax Profit Margin-3.16%3.82%1.24%9.31%8.48%
Net Profit Margin-3.38%2.36%3.38%7.87%6.45%
Continuous Operations Profit Margin-3.38%2.36%3.38%7.87%6.45%
Net Income Per EBT107.05%61.64%272.90%84.52%76.03%
EBT Per EBIT-2289.77%51.11%24.66%76.47%65.66%
Return on Assets (ROA)-0.98%0.76%0.95%2.27%1.75%
Return on Equity (ROE)-1.95%1.56%1.98%4.99%4.05%
Return on Capital Employed (ROCE)0.05%2.92%1.67%4.27%4.18%
Return on Invested Capital (ROIC)0.05%1.72%1.63%3.51%3.12%
Return on Tangible Assets-2.44%2.04%2.66%6.47%4.65%
Earnings Yield-1.65%1.51%2.22%4.67%4.22%
Efficiency Ratios
Receivables Turnover5.126.326.115.914.93
Payables Turnover3.185.124.474.053.74
Inventory Turnover1.121.301.181.261.30
Fixed Asset Turnover2.122.332.142.382.25
Asset Turnover0.290.320.280.290.27
Working Capital Turnover Ratio13.2835.2252.8022.135.14
Cash Conversion Cycle282.46267.72286.63260.99257.84
Days of Sales Outstanding71.3057.7859.7261.7874.08
Days of Inventory Outstanding325.77281.18308.49289.42281.35
Days of Payables Outstanding114.6171.2581.5890.2097.59
Operating Cycle397.07338.96368.21351.20355.43
Cash Flow Ratios
Operating Cash Flow Per Share330.60329.27228.94314.84359.16
Free Cash Flow Per Share198.97211.0375.30110.67299.67
Dividend Paid and CapEx Coverage Ratio1.431.550.931.072.39
Capital Expenditure Coverage Ratio2.512.781.491.546.04
Operating Cash Flow Coverage Ratio0.210.230.150.220.26
Operating Cash Flow to Sales Ratio0.230.230.170.240.31
Free Cash Flow Yield6.77%9.46%3.63%5.06%17.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-60.7665.2545.0221.4123.68
Price-to-Sales (P/S) Ratio2.051.561.521.691.53
Price-to-Book (P/B) Ratio1.191.030.891.070.96
Price-to-Free Cash Flow (P/FCF) Ratio14.7710.5727.5319.775.81
Price-to-Operating Cash Flow Ratio8.896.779.056.954.85
Price-to-Earnings Growth (PEG) Ratio0.25-2.53-0.820.55-0.61
Enterprise Value Multiple18.669.339.508.287.56
Enterprise Value13.56T11.29T10.87T10.64T8.94T
EV to EBITDA18.669.339.508.287.56
EV to Sales3.012.462.552.642.51
EV to Free Cash Flow21.6416.6646.1430.979.54
EV to Operating Cash Flow13.0210.6815.1810.897.96
Tangible Book Value Per Share-463.43-629.15-770.48-871.79-813.17
Shareholders’ Equity Per Share2478.412159.982324.542047.331817.40
Tax and Other Ratios
Effective Tax Rate-0.070.38-1.730.150.24
Revenue Per Share1430.331426.961362.701297.671141.35
Net Income Per Share-48.3833.6146.04102.1473.57
Tax Burden1.070.622.730.850.76
Interest Burden-24.680.390.110.610.50
Research & Development to Revenue0.150.160.170.160.15
SG&A to Revenue0.240.240.000.000.00
Stock-Based Compensation to Revenue0.020.020.020.020.01
Income Quality-6.859.784.973.084.88

Currency in JPY